BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3284818)

  • 1. Expression of class II MHC gene products by macrophages in human uteroplacental tissue.
    Bulmer JN; Morrison L; Smith JC
    Immunology; 1988 Apr; 63(4):707-14. PubMed ID: 3284818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA Class I protein expression in the human placenta.
    Blaschitz A; Hutter H; Dohr G
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of HLA class II antigens on human fetal and adult lymphocytes and macrophages.
    Edwards JA; Jones DB; Evans PR; Smith JL
    Immunology; 1985 Jul; 55(3):489-500. PubMed ID: 3894221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical analysis of the expression of HLA on the trophoblast of normal pregnancy].
    Honma S; Endou M; Uchiyama M; Nakamura M; Kanazawa K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):737-43. PubMed ID: 2671202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage populations in the human placenta and amniochorion.
    Bulmer JN; Johnson PM
    Clin Exp Immunol; 1984 Aug; 57(2):393-403. PubMed ID: 6380834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR positive cells in the human placenta.
    Sutton L; Mason DY; Redman CW
    Immunology; 1983 May; 49(1):103-12. PubMed ID: 6220962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of class II MHC gene products by fallopian tube epithelium in pregnancy and throughout the menstrual cycle.
    Bulmer JN; Earl U
    Immunology; 1987 Jun; 61(2):207-13. PubMed ID: 3298023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The secretory immune system as part of the placental barrier in the second trimester of pregnancy in humans.
    Ben-Hur H; Gurevich P; Berman V; Tchanyshev R; Gurevich E; Zusman I
    In Vivo; 2001; 15(5):429-35. PubMed ID: 11695242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cells bearing class II MHC antigens in the human placenta and amniochorion.
    Sutton L; Gadd M; Mason DY; Redman CW
    Immunology; 1986 May; 58(1):23-9. PubMed ID: 3086220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of class II MHC antigens in placentae from patients with pemphigoid gestationis: analysis of class II MHC subregion product expression.
    Borthwick GM; Holmes RC; Stirrat GM
    Placenta; 1988; 9(1):81-94. PubMed ID: 3283723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of class II HLA molecules by endothelial cells of human decidua.
    García-Tortosa C; Vargas ML; Cámara M; Alemán P; Montes MJ; Ruiz C; García-Olivares E
    Life Sci; 1993; 52(24):1947-54. PubMed ID: 8505860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DC-sign+ CD163+ macrophages expressing hyaluronan receptor LYVE-1 are located within chorion villi of the placenta.
    Böckle BC; Sölder E; Kind S; Romani N; Sepp NT
    Placenta; 2008 Feb; 29(2):187-92. PubMed ID: 18078989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human uteroplacental interface.
    Jokhi PP; Chumbley G; King A; Gardner L; Loke YW
    Lab Invest; 1993 Mar; 68(3):308-20. PubMed ID: 8450649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
    Brooks CF; Moore M
    Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age.
    Lambropoulou M; Tamiolakis D; Venizelos J; Liberis V; Galazios G; Tsikouras P; Karamanidis D; Petrakis G; Constantinidis T; Menegaki M; Papadopoulos N
    Clin Exp Med; 2006 Dec; 6(4):171-6. PubMed ID: 17191109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of non-lymphoid cells expressing HLA-D region antigens in human fetal gut.
    Spencer J; MacDonald TT; Isaacson PG
    Clin Exp Immunol; 1987 Feb; 67(2):415-24. PubMed ID: 3301095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of human fetal macrophages from placenta.
    Sutton LN; Mason DY; Redman CW
    Clin Exp Immunol; 1989 Dec; 78(3):437-43. PubMed ID: 2532993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II reactivity of human villous trophoblast in chronic inflammation of unestablished etiology.
    Labarrere CA; Faulk WP
    Transplantation; 1990 Nov; 50(5):812-6. PubMed ID: 2238057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phenotype of human placental macrophages and its variation with gestational age.
    Goldstein J; Braverman M; Salafia C; Buckley P
    Am J Pathol; 1988 Dec; 133(3):648-59. PubMed ID: 3264459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.